The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

Share Price Information for Biome Tech (BIOM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 72.50
Bid: 60.00
Ask: 85.00
Change: 0.00 (0.00%)
Spread: 25.00 (41.667%)
Open: 72.50
High: 76.00
Low: 76.00
Prev. Close: 76.00
BIOM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

7 Nov 2008 07:00

RNS Number : 6725H
Stanelco PLC
07 November 2008
 



7th November 2008

STANELCO PLC ("the Company" or "the Group")

Interim Management Statement

The Board of Stanelco Plc today issues its interim management statement for the nine month period ended 30 September 2008.

Overview

The first nine months of the year saw 120% growth in sales revenue to £12.2m compared with the same period last year (2007: £5.6m). We continued to make progress in reducing our operating losses.

Divisional Performance

BioPlastics

Commercialisation of the bioplastics technology continues as the Company broadens its base of regular customers, which is now developed across a variety of European markets.

Sales of bioplastics, made directly by Stanelcoare now up 450compared to the same 9 month period last year. Direct sales in the third quarter were up 24% on the second quarter, reaching £1.4m year-to-date.

In the third quarter the Company opened a small sales office in the USA to begin the process of exploiting the emerging opportunity for sustainable bioplastics in North America. This renewed activity is being driven by an experienced plastics industry professional and is already creating an encouraging pipeline of trials.

We have continued to strengthen the BioPlastics division in the UK by recruiting further senior technical and customer support expertise with substantive relevant expertise.  

Further minor investment in development and testing equipment was also made at the UK development facility in the period. Development trials continue to establish pace and laboratory success, with a number of new products having moved to pre-commercial trials with several customers.

RF Applications

In RF Applications divisionthe strong enquiry book is gradually being converted into orders and we expect to see some benefit of that in the second half as the General Manager and newly appointed Sales Manager begin to achieve traction.

The optical fiber furnace market continues to show encouraging signs, driven by continued fiber demand in Asia. In the third quarter, Stanelco continued to strengthen its position in China with its first order for its new generation of higher capacity furnaces powered by Stanelco's new RF generator.

There is also growing interest in the newly developed mobile welding products. However, the long lead times from enquiry to order mean that this is likely to have limited impact on this financial year's results.

Financial Position

We continue to maintain a strong balance sheet. Our cash position at 30 September was £6.9mstrengthened since the half year by working capital movements related to stock reduction.

Outlook 

Our strategy is clear and good progress is being made. We continue to look for compatible and sensible investment opportunities.

We remain alert to the rapidly changing economic conditions throughout the worldbut we have not seen an impact on our business as yet. The Board's expectations for the financial performance for 2008 remain in line with those set earlier in the year.

Ends -

Paul Mines, Chief Executive, Stanelco plc

Clive Warner, Finance Director, Stanelco plc

Tel: +44 (0) 2380 867 100

Jonathon Brill/Caroline Stewart

Financial Dynamics

Tel: +44 (0) 20 7831 3113

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBFBPTMMIMBBP
Date   Source Headline
29th Apr 20247:01 amRNSTrading Update
29th Apr 20247:00 amRNSFinal Results 2023
15th Mar 20247:00 amRNSContract win for Stanelco RF Division
11th Mar 20241:59 pmRNSIssue of Convertible Loan Notes, PDMR Notification
15th Feb 20242:54 pmRNSContract win for RF Division
6th Feb 20247:00 amRNSTrading Update
13th Nov 20237:00 amRNSTrading Update
10th Oct 20234:32 pmRNSGrant of Options
27th Sep 20237:00 amRNSInterim Results
26th Jul 20237:00 amRNSTrading Update
30th Jun 20235:00 pmRNSTotal Voting Rights
22nd Jun 20237:00 amRNSContract win for Stanelco RF Division
31st May 20237:00 amRNSIssue of Equity, Director/PDMR Shareholding & TVR
25th May 20232:57 pmRNSAppointment of Non-Executive Director
25th May 202312:45 pmRNSResult of AGM
2nd May 20231:05 pmRNSDirector/PDMR Shareholding
27th Apr 20237:00 amRNSNotice of AGM and 2022 Annual Report
26th Apr 20237:01 amRNSTrading Update
26th Apr 20237:00 amRNSFinal Results 2022
18th Apr 202310:49 amRNSCompletion of CLN Fundraising
17th Apr 202311:30 amRNSResult of General Meeting
31st Mar 202311:14 amRNSProposed issue of Convertible Loan Notes
25th Jan 20237:00 amRNSTrading Update
16th Nov 20227:00 amRNSBiome receives £282k grant
10th Nov 202211:05 amRNSSecond Price Monitoring Extn
10th Nov 202211:00 amRNSPrice Monitoring Extension
10th Nov 20227:00 amRNSTrading Update
18th Oct 20229:28 amRNSHolding(s) in Company
22nd Sep 20224:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20224:36 pmRNSPrice Monitoring Extension
22nd Sep 20222:05 pmRNSSecond Price Monitoring Extn
22nd Sep 20222:00 pmRNSPrice Monitoring Extension
22nd Sep 20229:05 amRNSSecond Price Monitoring Extn
22nd Sep 20229:00 amRNSPrice Monitoring Extension
22nd Sep 20227:00 amRNSInterim Results
5th Sep 20227:00 amRNSGrant funding from Innovate UK
2nd Aug 20228:59 amRNSTrading Update - Replacement
2nd Aug 20227:00 amRNSTrading Update
20th Apr 202212:01 pmRNSResult of Annual General Meeting
20th Apr 20227:00 amRNSTrading Update
30th Mar 20222:48 pmRNSDirector/PDMR Shareholding
30th Mar 20227:00 amRNSNotice of AGM and 2021 Annual Report
24th Mar 20227:00 amRNSFinal Results 2021
27th Jan 20227:00 amRNSTrading Update
4th Jan 202210:33 amRNSFurther substantial contract win for RF Division
16th Dec 20218:41 amRNSContract
17th Nov 20217:00 amRNSTrading Update
9th Nov 202111:12 amRNSHolding(s) in Company
25th Oct 20217:00 amRNSUpdate re biodegradable tree shelters
15th Sep 20217:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.